Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
about
Integrative analysis of neuroblastoma and pheochromocytoma genomics data.11q deletion in neuroblastoma: a review of biological and clinical implications.Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastomaThe role of complex genomic alterations in neuroblastoma risk estimation.Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.Frequent loss of the BLID gene in early-onset breast cancer.Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastomaMYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma.Therapeutic targeting of miRNAs in neuroblastoma.Genetic stratification of neuroblastoma for treatment tailoring.The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastomaA 6-gene signature identifies four molecular subgroups of neuroblastomaIntegrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.
P2860
Q30575178-AAA8C7E8-0E2E-4133-BA33-47BB78328C48Q32174267-44405A46-4441-416A-8E66-9DB6B2E30A41Q33891984-F950657F-3BE7-415B-9ED5-EF9B29E25802Q33918821-C500E537-41A9-46C5-85E7-8B94E606DFE4Q34558670-96368856-84C9-4FD2-BC9B-FA2184B6EAE9Q34611561-7DCF6477-1EEA-49CF-B03A-59159B2ECD51Q34711056-015667D7-B314-4E89-98FA-9954235F6897Q35042737-0BA2BBA2-4B5E-4F81-9243-769C5E0AA8ABQ35545663-65D7C9F6-FD14-4992-9544-AEFFE957DD7CQ35677257-1D317842-3AA3-471D-BC54-23CC6C3842F0Q36890247-B748C4CD-10B7-4561-8D27-980C36E990F5Q37731564-915D0AA9-ABB5-401A-A1E9-6785180CFAEAQ37775637-0F958120-D461-43F0-8452-33E6B1779112Q37932545-FD401196-6E60-4B7D-AC66-246F4DB46777Q38070334-78DFA622-2C7B-450B-9CFF-F935FFD21D17Q38817378-B2977315-AD1D-441F-9551-C75CD9C3F1DDQ41980747-EC0D2B66-EF8B-4A97-911F-93B47A83CACCQ44588158-7F84AD96-6018-4036-8C33-C3C6B88B7927
P2860
Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
description
im November 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2009
@uk
name
Integrated genomic profiling i ...... ma with loss of chromosome 11q
@en
Integrated genomic profiling i ...... ma with loss of chromosome 11q
@nl
type
label
Integrated genomic profiling i ...... ma with loss of chromosome 11q
@en
Integrated genomic profiling i ...... ma with loss of chromosome 11q
@nl
prefLabel
Integrated genomic profiling i ...... ma with loss of chromosome 11q
@en
Integrated genomic profiling i ...... ma with loss of chromosome 11q
@nl
P2093
P2860
P50
P356
P1433
P1476
Integrated genomic profiling i ...... ma with loss of chromosome 11q
@en
P2093
A Oberthür
F Berthold
F Westermann
J Theissen
P2860
P2888
P304
P356
10.1038/ONC.2009.390
P407
P577
2009-11-09T00:00:00Z
P6179
1036050781